Clinical Trial Update: A Study of PHST001 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Pheast Therapeutics is recruiting for a Phase 1 study of PHST001 in patients with advanced solid tumors, including ovarian cancer, endometrial cancer, cholangio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors
• Cholangiocarcinoma
• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• PHST001

Snippet

Sponsor: Pheast Therapeutics | Conditions: Advanced Solid Tumors, Ovarian Cancer | Phase 1 | Status: RECRUITING